KAS
BMRN icon

Kestra Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kestra Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+3,663
New +$201K ﹤0.01% 3077
2024
Q4 		– Sell
-9,754
Closed -$686K – 2672
2024
Q3 		$686K Buy
9,754
+620
+7% +$51.8K ﹤0.01% 1558
2024
Q2 		$752K Sell
9,134
-9,251
-50% -$770K ﹤0.01% 1500
2024
Q1 		$1.61M Buy
18,385
+3,095
+20% +$277K 0.01% 984
2023
Q4 		$1.47M Buy
15,290
+1,456
+11% +$129K 0.01% 949
2023
Q3 		$1.22M Buy
13,834
+2,817
+26% +$251K 0.01% 902
2023
Q2 		$955K Buy
11,017
+712
+7% +$67K 0.01% 1002
2023
Q1 		$1M Buy
10,305
+558
+6% +$57.8K 0.01% 947
2022
Q4 		$1.01M Buy
9,747
+3,001
+44% +$282K 0.01% 1053
2022
Q3 		$572K Buy
6,746
+449
+7% +$40K 0.01% 1243
2022
Q2 		$522K Sell
6,297
-1,714
-21% -$136K 0.01% 1308
2022
Q1 		$618K Buy
8,011
+4,277
+115% +$358K 0.01% 1172
2021
Q4 		$330K Sell
3,734
-237
-6% -$19.6K ﹤0.01% 1547
2021
Q3 		$307K Buy
3,971
+300
+8% +$23.7K ﹤0.01% 1652
2021
Q2 		$306K Buy
3,671
+408
+13% +$32.3K ﹤0.01% 1552
2021
Q1 		$246K Buy
+3,263
New +$267K ﹤0.01% 1590

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Kestra Advisory Services's BMRN Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 3,663 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #3077 among its holdings. This is a return to the name: Kestra Advisory Services previously reported a position in BMRN as recently as Q3 2024.

Kestra Advisory Services first reported a position in BMRN in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.61M in Q1 2024. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Kestra Advisory Services held 3,663 shares of BioMarin Pharmaceuticals worth $210K as of Q2 2026.
  • BioMarin Pharmaceuticals was a new Kestra Advisory Services position in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3077 holding.
  • Kestra Advisory Services first reported a position in BioMarin Pharmaceuticals in Q1 2021 and has held it in 16 quarters since.
  • Kestra Advisory Services's BioMarin Pharmaceuticals position peaked at $1.61M in Q1 2024.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.